PFE, Takeda ink Japanese co-promotion for Enbrel, Tofacitinib (PFE’s JAK inhibitor f/k/a tasocitinib): http://finance.yahoo.com/news/New-CoPromotion-Agreements-bw-265312336.html?x=0&.v=1 Financial terms were not disclosed.